1 |
Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 1990;40(2):277-280
DOI
|
2 |
Moore AP, Wood GD. The medical management of masseteric hypertrophy with botulinum toxin type A. Br J Oral Maxillofac Surg 1994;32(1):26-28
DOI
ScienceOn
|
3 |
Freund B, Schwartz M, Symington JM. The use of botulinum toxin for the treatment of temporomandibular disorder: preliminary findings. J Oral Maxillofac Surg 1999;57(8):916-920
DOI
PUBMED
ScienceOn
|
4 |
Gurney CE. Chronic bilateral benign hypertrophy of the masseter muscles. Am J Surg 1947;73:137-139
DOI
ScienceOn
|
5 |
Kim HJ, Yum KW, Lee SS, Heo MS, Seo K. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomograpic management. Dermatol Surg 2003;29(5):484-489
DOI
ScienceOn
|
6 |
장희영. 전산화 단층촬영으로 평가한 교근에 대한 보툴리눔 A 형 독소주사와 교합안정장치의 효과. 연세대학교 치의학과 박사논문, 2004
|
7 |
Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 1994;9(1):31-39
DOI
ScienceOn
|
8 |
Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol soc 1981;79:734-770
|
9 |
To EW, Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, Hui AC. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001;54:197-200
DOI
ScienceOn
|
10 |
von Lindern JJ, Niederhagen B, Appel T, Berge S, Reich RH. Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plast Reconstr Surg 2001;107:327-332
DOI
ScienceOn
|
11 |
Binz T, Blasi J, Yamasaki S, Baumeister A, Link E, Sudhof TC, Jahn R, Niemann H. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem 1994;269(3):1617-1620
|
12 |
Ivanhoe CB, Lai JM, Francisco GE. Bruxim after brain injury: Successful treatment with botulinum toxin-A. Arch Phys Med Rehabil 1997;78:1272-1273
DOI
ScienceOn
|
13 |
Legg JW. Enlargement of the temporal and masseter muscles on both sides. Trans Pathol Soc Lond 1880;31:361
|
14 |
Smyth AG. Botulinum toxin treatment of bilateral masseteric hypertrophy. Br J Oral Maxillofac Surg 1994;32(1):29-33
DOI
ScienceOn
|
15 |
Niamtu J 3rd. Aesthetic uses of botulinum toxin A. J Oral Maxillofac Surg 1999;57(10):1228-1233
DOI
PUBMED
ScienceOn
|
16 |
Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM. Botulinum toxin type A(BOTOX) for treatment of migraine headaches; an open-label study. Otolaryngol Head Neck Surg 2000;123(6):669-676
DOI
PUBMED
ScienceOn
|
17 |
Park MY, Ahn KY, Jung DS. Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg 2003;29(5):477-483
DOI
ScienceOn
|
18 |
Turton K, Chaddock JA, Acharya KR. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci 2002;27(11): 552-558
DOI
PUBMED
ScienceOn
|
19 |
Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migrane preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache 2000;40(6):445-450
DOI
ScienceOn
|
20 |
Pidcock FS, Wise JM, Christensen JR. Treatment of severe post-traumatic bruxism with botulinum toxin-A: Case report. J Oral Maxillofac Surg 2002;60:115-117
DOI
ScienceOn
|